Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01047007
What this trial is testing

A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005

Who this might be right for
Solid Tumors
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)UnknownNCT04503967
What this trial is testing

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 48
Early research (Phase 1)UnknownNCT03507998
What this trial is testing

Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+4 more
Curegenix Inc. 39
Testing effectiveness (Phase 2)UnknownNCT03829345
What this trial is testing

A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

Who this might be right for
Oesophageal CancerGastro-Oesophageal Junction CancerGastric Cancer
Royal Marsden NHS Foundation Trust 54
Testing effectiveness (Phase 2)Looking for participantsNCT06239194
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Who this might be right for
Biliary Tract CancerBreast CancerCervical Cancer+13 more
ModeX Therapeutics, An OPKO Health Company 285
Testing effectiveness (Phase 2)UnknownNCT05522894
What this trial is testing

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Who this might be right for
Unresectable Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 80
Large-scale testing (Phase 3)UnknownNCT03790553
What this trial is testing

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 646
Very early researchWithdrawnNCT02857218
What this trial is testing

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Who this might be right for
Stage IIB Esophageal Cancer AJCC v7Stage III Esophageal Cancer AJCC v7Stage IIIA Esophageal Cancer AJCC v7+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Not applicableLooking for participantsNCT04117100
What this trial is testing

Advanced Endo-therapeutic Procedure : Registry-based Observational Study

Who this might be right for
Zenker DiverticulumPolyp of ColonColo-rectal Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 500
Early research (Phase 1)Looking for participantsNCT06545331
What this trial is testing

Study of XB010 in Subjects With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsEsophageal Squamous Cell CancerHead and Neck Squamous Cell Cancer+3 more
Exelixis 396
Testing effectiveness (Phase 2)Ended earlyNCT04189445
What this trial is testing

Futibatinib in Patients With Specific FGFR Aberrations

Who this might be right for
Advanced or Metastatic Solid TumorAdvanced or Metastatic Gastric or Gastroesophageal CancerMyeloid or Lymphoid Neoplasms (MLN)
Taiho Oncology, Inc. 115
Early research (Phase 1)Not Yet RecruitingNCT06748872
What this trial is testing

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Who this might be right for
Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more
Medigene AG 55
Early research (Phase 1)Study completedNCT00701857
What this trial is testing

Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
University of Arizona 10
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Ended earlyNCT00101907
What this trial is testing

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Who this might be right for
Lung CancerPancreatic CancerEsophageal Cancer
Amgen 41
Early research (Phase 1)Study completedNCT00601692
What this trial is testing

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 27
Early research (Phase 1)Not Yet RecruitingNCT07806500
What this trial is testing

Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors

Who this might be right for
Squamous Cell Lung CancerGastric CancerEsophageal Cancer
Beijing Anjianxi Bio-Medical Technology Co., Ltd. 18
Large-scale testing (Phase 3)Looking for participantsNCT05677490
What this trial is testing

MFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+12 more
Alliance for Clinical Trials in Oncology 382
Testing effectiveness (Phase 2)Looking for participantsNCT05473156
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)+1 more
AP Biosciences Inc. 168
Next Page